Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

FGFR1 signaling in rheumatoid arthritis: Mechanisms of bone destruction and therapeutic targeting (Review).

International journal of molecular medicine·2026
Same author

Neuropilin‑1: Emerging roles in nerve‑vessel‑bone coupling during fracture repair (Review).

International journal of molecular medicine·2026
Same author

Hesperetin and Naringenin promote glucagon-like peptide-1 secretion from L-cell through activation of TGR5 and alleviated type 2 diabetes.

Frontiers in pharmacology·2026
Same author

Cucurbitacin B attenuates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via PI3K/AKT/mTOR signaling.

International immunopharmacology·2026
Same author

Transcriptomic analysis of the effects of dietary chitosan on the molting process in Procambarus clarkii.

Developmental and comparative immunology·2026
Same author

Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer.

Cell reports. Medicine·2026

相关实验视频

Updated: Jun 23, 2025

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
00:06

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Published on: August 23, 2019

7.0K

一个新的药物微生物群相互作用评估系统.

Tian-Hao Liu1,2,3, Chen-Yang Zhang3,4, Hang Zhang5

  • 1Yu-Yue Pathology Scientific Research Center Chongqing China.

iMeta
|June 20, 2024
PubMed
概括

药物反应的个体变异性 (IVDR) 受肠道微生物群的影响,由遗传学和环境塑造. 了解这些药物微生物群相互作用是提高药物疗效和减少临床试验失败的关键.

关键词:
药物代谢 药物代谢药物微生物群的相互作用遗传因素和环境因素.我们的肠道微生物群.

更多相关视频

High Throughput Co-culture Assays for the Investigation of Microbial Interactions
07:00

High Throughput Co-culture Assays for the Investigation of Microbial Interactions

Published on: October 15, 2019

9.8K
A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
07:54

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

14.3K

相关实验视频

Last Updated: Jun 23, 2025

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
00:06

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Published on: August 23, 2019

7.0K
High Throughput Co-culture Assays for the Investigation of Microbial Interactions
07:00

High Throughput Co-culture Assays for the Investigation of Microbial Interactions

Published on: October 15, 2019

9.8K
A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
07:54

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

14.3K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 微生物学 微生物学
  • 遗传学 是一个遗传学.

背景情况:

  • 药物反应是多因素的,受遗传学和环境的影响.
  • 基因向药物的高临床失败率凸显了需要考虑环境因素和药物反应 (IVDR) 的个体变化.
  • 肠道微生物群的组成和药物代谢主要是由环境变量决定的,而不是疾病本身.

研究的目的:

  • 讨论肠道微生物群如何影响宿主的药物吸收,分布,新陈代谢和分泌 (ADME) 微环境.
  • 提出一种新的药物与微生物群相互作用的评估系统.
  • 引入一种新的研究方法,用于研究体内药物-微生物群相互作用.

主要方法:

  • 对环境因素,肠道微生物群和药物代谢的现有证据的审查.
  • 对药物与微生物群相互作用的新评估系统的概念化.
  • 关于使用无菌动物模型进行自上而下的研究方法的建议.

主要成果:

  • 肠道微生物群的个体差异创造了独特的代谢环境,影响了体内ADME过程.
  • 肠道微生物群受到遗传和环境因素的影响,对宿主的ADME微环境产生重大影响.
  • 无细菌动物模型为新的药物微生物群相互作用评估系统提供了基础.

结论:

  • 环境因素和个体肠道微生物群的组成是药物反应的关键决定因素.
  • 对药物-微生物群相互作用的全面理解对于改善药物开发和临床结果至关重要.
  • 拟议的研究方法和评估系统为更好地预测和管理IVDR提供了一条途径.